Academic Journal
Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer
| العنوان: | Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer |
|---|---|
| المصدر: | UroGEC/BRAPHYQS group of the GEC ESTRO 2016 , ' Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer ' , Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology , vol. 120 , no. 2 , pp. 293-9 . https://doi.org/10.1016/j.radonc.2016.05.026 |
| سنة النشر: | 2016 |
| المجموعة: | The University of Manchester: Research Explorer - Publications |
| مصطلحات موضوعية: | Brachytherapy/adverse effects, Dose-Response Relationship, Radiation, Humans, Male, Models, Biological, Neoplasms, Radiation-Induced/etiology, Second Primary/etiology, Prostatic Neoplasms/diagnostic imaging, Radiotherapy Dosage, Rectal Neoplasms/etiology, Rectum/radiation effects, Risk, Tomography, X-Ray Computed/methods, Urinary Bladder/radiation effects, Urinary Bladder Neoplasms/etiology, ResearchInstitutes_Networks_Beacons/mcrc, Manchester Cancer Research Centre |
| الوصف: | BACKGROUND AND PURPOSE: To estimate the risks of radiation-induced rectal and bladder cancers following low dose rate (LDR) and high dose rate (HDR) brachytherapy as monotherapy for localised prostate cancer and compare to external beam radiotherapy techniques. MATERIALS AND METHODS: LDR and HDR brachytherapy monotherapy plans were generated for three prostate CT datasets. Second cancer risks were assessed using Schneider's concept of organ equivalent dose. LDR risks were assessed according to a mechanistic model and a bell-shaped model. HDR risks were assessed according to a bell-shaped model. Relative risks and excess absolute risks were estimated and compared to external beam techniques. RESULTS: Excess absolute risks of second rectal or bladder cancer were low for both LDR (irrespective of the model used for calculation) and HDR techniques. Average excess absolute risks of rectal cancer for LDR brachytherapy according to the mechanistic model were 0.71 per 10,000 person-years (PY) and 0.84 per 10,000 PY respectively, and according to the bell-shaped model, were 0.47 and 0.78 per 10,000 PY respectively. For HDR, the average excess absolute risks for second rectal and bladder cancers were 0.74 and 1.62 per 10,000 PY respectively. The absolute differences between techniques were very low and clinically irrelevant. Compared to external beam prostate radiotherapy techniques, LDR and HDR brachytherapy resulted in the lowest risks of second rectal and bladder cancer. CONCLUSIONS: This study shows both LDR and HDR brachytherapy monotherapy result in low estimated risks of radiation-induced rectal and bladder cancer. LDR resulted in lower bladder cancer risks than HDR, and lower or similar risks of rectal cancer. In absolute terms these differences between techniques were very small. Compared to external beam techniques, second rectal and bladder cancer risks were lowest for brachytherapy. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| DOI: | 10.1016/j.radonc.2016.05.026 |
| الاتاحة: | https://research.manchester.ac.uk/en/publications/834e88b3-ee50-4aa3-b2de-594086c1d989 https://doi.org/10.1016/j.radonc.2016.05.026 https://pure.manchester.ac.uk/ws/files/85104167/HenryModelling_second_malignancy_risks_from_Low_Dose_Rate_.pdf http://eprints.whiterose.ac.uk/101262/3/HenryModelling%20second%20malignancy%20risks%20from%20Low%20Dose%20Rate%20.pdf |
| Rights: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.B28C22B7 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.B28C22B7 863 3 Academic Journal academicJournal 863.477478027344 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.B28C22B7&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://research.manchester.ac.uk/en/publications/834e88b3-ee50-4aa3-b2de-594086c1d989# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer
)
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => UroGEC/BRAPHYQS group of the GEC ESTRO 2016 , ' Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer ' , Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology , vol. 120 , no. 2 , pp. 293-9 . https://doi.org/10.1016/j.radonc.2016.05.026 ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2016 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => The University of Manchester: Research Explorer - Publications ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Brachytherapy%2Fadverse+effects%22">Brachytherapy/adverse effects</searchLink><br /><searchLink fieldCode="DE" term="%22Dose-Response+Relationship%22">Dose-Response Relationship</searchLink><br /><searchLink fieldCode="DE" term="%22Radiation%22">Radiation</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Models%22">Models</searchLink><br /><searchLink fieldCode="DE" term="%22Biological%22">Biological</searchLink><br /><searchLink fieldCode="DE" term="%22Neoplasms%22">Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Radiation-Induced%2Fetiology%22">Radiation-Induced/etiology</searchLink><br /><searchLink fieldCode="DE" term="%22Second+Primary%2Fetiology%22">Second Primary/etiology</searchLink><br /><searchLink fieldCode="DE" term="%22Prostatic+Neoplasms%2Fdiagnostic+imaging%22">Prostatic Neoplasms/diagnostic imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Radiotherapy+Dosage%22">Radiotherapy Dosage</searchLink><br /><searchLink fieldCode="DE" term="%22Rectal+Neoplasms%2Fetiology%22">Rectal Neoplasms/etiology</searchLink><br /><searchLink fieldCode="DE" term="%22Rectum%2Fradiation+effects%22">Rectum/radiation effects</searchLink><br /><searchLink fieldCode="DE" term="%22Risk%22">Risk</searchLink><br /><searchLink fieldCode="DE" term="%22Tomography%22">Tomography</searchLink><br /><searchLink fieldCode="DE" term="%22X-Ray+Computed%2Fmethods%22">X-Ray Computed/methods</searchLink><br /><searchLink fieldCode="DE" term="%22Urinary+Bladder%2Fradiation+effects%22">Urinary Bladder/radiation effects</searchLink><br /><searchLink fieldCode="DE" term="%22Urinary+Bladder+Neoplasms%2Fetiology%22">Urinary Bladder Neoplasms/etiology</searchLink><br /><searchLink fieldCode="DE" term="%22ResearchInstitutes%5FNetworks%5FBeacons%2Fmcrc%22">ResearchInstitutes_Networks_Beacons/mcrc</searchLink><br /><searchLink fieldCode="DE" term="%22Manchester+Cancer+Research+Centre%22">Manchester Cancer Research Centre</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => BACKGROUND AND PURPOSE: To estimate the risks of radiation-induced rectal and bladder cancers following low dose rate (LDR) and high dose rate (HDR) brachytherapy as monotherapy for localised prostate cancer and compare to external beam radiotherapy techniques. MATERIALS AND METHODS: LDR and HDR brachytherapy monotherapy plans were generated for three prostate CT datasets. Second cancer risks were assessed using Schneider's concept of organ equivalent dose. LDR risks were assessed according to a mechanistic model and a bell-shaped model. HDR risks were assessed according to a bell-shaped model. Relative risks and excess absolute risks were estimated and compared to external beam techniques. RESULTS: Excess absolute risks of second rectal or bladder cancer were low for both LDR (irrespective of the model used for calculation) and HDR techniques. Average excess absolute risks of rectal cancer for LDR brachytherapy according to the mechanistic model were 0.71 per 10,000 person-years (PY) and 0.84 per 10,000 PY respectively, and according to the bell-shaped model, were 0.47 and 0.78 per 10,000 PY respectively. For HDR, the average excess absolute risks for second rectal and bladder cancers were 0.74 and 1.62 per 10,000 PY respectively. The absolute differences between techniques were very low and clinically irrelevant. Compared to external beam prostate radiotherapy techniques, LDR and HDR brachytherapy resulted in the lowest risks of second rectal and bladder cancer. CONCLUSIONS: This study shows both LDR and HDR brachytherapy monotherapy result in low estimated risks of radiation-induced rectal and bladder cancer. LDR resulted in lower bladder cancer risks than HDR, and lower or similar risks of rectal cancer. In absolute terms these differences between techniques were very small. Compared to external beam techniques, second rectal and bladder cancer risks were lowest for brachytherapy. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1016/j.radonc.2016.05.026 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://research.manchester.ac.uk/en/publications/834e88b3-ee50-4aa3-b2de-594086c1d989<br />https://doi.org/10.1016/j.radonc.2016.05.026<br />https://pure.manchester.ac.uk/ws/files/85104167/HenryModelling_second_malignancy_risks_from_Low_Dose_Rate_.pdf<br />http://eprints.whiterose.ac.uk/101262/3/HenryModelling%20second%20malignancy%20risks%20from%20Low%20Dose%20Rate%20.pdf ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => info:eu-repo/semantics/openAccess ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.B28C22B7 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1016/j.radonc.2016.05.026
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Brachytherapy/adverse effects
[Type] => general
)
[1] => Array
(
[SubjectFull] => Dose-Response Relationship
[Type] => general
)
[2] => Array
(
[SubjectFull] => Radiation
[Type] => general
)
[3] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[4] => Array
(
[SubjectFull] => Male
[Type] => general
)
[5] => Array
(
[SubjectFull] => Models
[Type] => general
)
[6] => Array
(
[SubjectFull] => Biological
[Type] => general
)
[7] => Array
(
[SubjectFull] => Neoplasms
[Type] => general
)
[8] => Array
(
[SubjectFull] => Radiation-Induced/etiology
[Type] => general
)
[9] => Array
(
[SubjectFull] => Second Primary/etiology
[Type] => general
)
[10] => Array
(
[SubjectFull] => Prostatic Neoplasms/diagnostic imaging
[Type] => general
)
[11] => Array
(
[SubjectFull] => Radiotherapy Dosage
[Type] => general
)
[12] => Array
(
[SubjectFull] => Rectal Neoplasms/etiology
[Type] => general
)
[13] => Array
(
[SubjectFull] => Rectum/radiation effects
[Type] => general
)
[14] => Array
(
[SubjectFull] => Risk
[Type] => general
)
[15] => Array
(
[SubjectFull] => Tomography
[Type] => general
)
[16] => Array
(
[SubjectFull] => X-Ray Computed/methods
[Type] => general
)
[17] => Array
(
[SubjectFull] => Urinary Bladder/radiation effects
[Type] => general
)
[18] => Array
(
[SubjectFull] => Urinary Bladder Neoplasms/etiology
[Type] => general
)
[19] => Array
(
[SubjectFull] => ResearchInstitutes_Networks_Beacons/mcrc
[Type] => general
)
[20] => Array
(
[SubjectFull] => Manchester Cancer Research Centre
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer
[Type] => main
)
)
)
[BibRelationships] => Array
(
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2016
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => $2
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |